Didier Jean

13PUBLICATIONS
48CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Entinostat Enhances Antigen-Specific CD8 T-Cell Response to Immunotherapies in Lung Cancer Models.

|Nov 01, 2025
Intratumour, anatomical and temporal heterogeneity in mesothelioma.

Maya Arnould, Mark D J Neilly, Kevin G Blyth

|Sep 24, 2025
Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma.

Jean-Baptiste Assié, Clément Meiller, Esther Stern

|Feb 11, 2023
The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition.

Emanuela Felley-Bosco, Weihong Qi, Didier Jean

|Dec 01, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.

Sabine Paternot, Eric Raspé, Clément Meiller

|Oct 12, 2022
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.

Ananya Hariharan, Weihong Qi, Hubert Rehrauer

Pageof 3

Frequent Collaborators

3 joint publications

Yuna Blum

3 joint publications

Robin Tranchant

3 joint publications

Christophe Blanquart

2 joint publications

Jessica Zucman-Rossi